Clinical characteristics of branch retinal vein occlusion with increased retinal haemorrhage during treatment for macular oedema
暂无分享,去创建一个
[1] Chao Huang,et al. Short-term effect of intravitreal conbercept injection on major and macular branch retinal vein occlusion , 2019, The Journal of international medical research.
[2] M. Elçioğlu,et al. Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion. , 2018, International journal of ophthalmology.
[3] D. Călugăru,et al. Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up (BERVOLT study: bevacizumab for RVO long-term follow-up) , 2016, Graefe's Archive for Clinical and Experimental Ophthalmology.
[4] Sohan Singh Hayreh,et al. Ocular vascular occlusive disorders: Natural history of visual outcome , 2014, Progress in Retinal and Eye Research.
[5] S. K. Gibran,et al. Efficacy of combined intravitreal bevacizumab and triamcinolone for branch retinal vein occlusion , 2014, Indian journal of ophthalmology.
[6] M. Ali,et al. Cardiobacterium hominis-induced acute dacryocystitis and lacrimal abscess , 2014, Indian journal of ophthalmology.
[7] I. Chatziralli,et al. BRANCH RETINAL VEIN OCCLUSION: Epidemiology, Pathogenesis, Risk Factors, Clinical Features, Diagnosis, and Complications. An Update of the Literature , 2013, Retina.
[8] Sean M. Hartig,et al. Basic Image Analysis and Manipulation in ImageJ , 2013, Current protocols in molecular biology.
[9] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[10] P. Mitchell,et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. , 2010, Ophthalmology.
[11] Ingrid U Scott,et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5. , 2009, Archives of ophthalmology.
[12] S. Deka,et al. Rebound effect following intravitreal bevacizumab in branch retinal vein occlusion , 2009, Oman Journal of Ophthalmology.
[13] F. Badalà. The treatment of branch retinal vein occlusion with bevacizumab , 2008, Current opinion in ophthalmology.
[14] R. Avery,et al. INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSION , 2007, Retina.
[15] W. Farquhar,et al. Venous smooth muscle tone and responsiveness in older adults. , 2006, Journal of applied physiology.
[16] M. Tsaloumas,et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion , 2000, Eye.
[17] M. Zimmerman,et al. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. , 1994, American journal of ophthalmology.
[18] M. Shapiro,et al. Branch retinal vein occlusion and quadratic variation in arteriovenous crossings. , 1992, American journal of ophthalmology.
[19] D. Finkelstein,et al. Argon laser photocoagulation for macular edema in branch vein occlusion. , 1986, Ophthalmology.
[20] I. Constable,et al. Macular oedema and retinal branch vein occlusion. , 1980, Australian journal of ophthalmology.
[21] W. Annesley,et al. Macular branch vein occlusion. , 1980, Ophthalmology.
[22] Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. Branch Vein Occlusion Study Group. , 1986, Archives of ophthalmology.
[23] Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. , 1984, American journal of ophthalmology.
[24] K. Kadonosono,et al. Clinical Ophthalmology Dovepress Outcomes of Microincision Vitrectomy Surgery with Internal Limiting Membrane Peeling for Macular Edema Secondary to Branch Retinal Vein Occlusion , 2022 .